Companies: 10,795·Total market cap: $144.5T
Nemaura Medical Inc.

Nemaura Medical Inc.

NMRDOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$8070
P/E Ratio—
52W High$0.0005
52W Low$0.00001
Overview
股票排行：Medical - Devices·Healthcare·查看全部市值排行 →

Nemaura Medical Inc.（NMRD）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NMRD · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.22nmrd eps ttm · nmrd earnings per shareEarnings history
PE Ratio (TTM)—nmrd pe ratio ttm · nmrd price to earningsPE Ratio deep dive
Revenue (TTM)$-1.6Mnmrd revenue ttm · nmrd annual revenueFull revenue history
Dividend Yield不分红does nmrd pay dividends · nmrd dividend yieldDividend history
Shares Outstanding24.9Mnmrd shares outstanding · nmrd floatShares outstanding history
Next EarningsAug 10, 2026Est.nmrd earnings date · nmrd next earningsEarnings history

探索 Nemaura Medical Inc. 数据

nmrd stock data · financials
市值$8,070nmrd market cap · nmrd valuation
分析师预测$— · Buy
股息不分红does nemaura medical inc. pay dividends · nmrd dividend yield
营收$77044-84.71%nemaura medical inc. annual revenue · nmrd revenue
盈利EPS $-0.57+3.39%nmrd earnings · nmrd eps
市盈率—nmrd pe ratio · nmrd price to earnings

财务快照

完整财报
FY 2023Revenue$77044.00▼ 84.71% YoY
202120222023
nemaura medical inc. revenue · nmrd revenue 2023
FY 2023Net Income-$14.1M▼ 1.85% YoY
202120222023
nemaura medical inc. net income · nmrd profit 2023
FY 2023EPS$-0.57▲ +3.39% YoY
202120222023
nmrd eps · nemaura medical inc. earnings per share 2023
TTM:Revenue: -$1.6MNet Income: -$6.3MEPS: $-0.22View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy2 位分析师is nmrd a buy · nmrd analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$0.00Current
$—Avg Target
$—High
nmrd price target · nmrd 12 month forecast

合计: 2 · 买入占比: 100.0%

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+100.00%
3M+1900.00%
YTD+19900.00%
1Y+100.00%
5Y-100.00%

关于 Nemaura Medical Inc.

CEODewan Fazlul Hoque Chowdhury
IPO DateFeb 5, 2018
Employees36
CountryUS
Websitenemauramedical.com

Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices. Its flagship product, sugarBEAT, is an innovative, non-invas…

Medical - DevicesHealthcareOTCUS

what is nemaura medical inc. · nmrd stock overview · nemaura medical inc. company profile · who is nemaura medical inc. ceo · nmrd OTC · nemaura medical inc. headquarters · nemaura medical inc. business segments

关于股票概览与关键数据

Nemaura Medical Inc.（NMRD）是 Medical - Devices 行业的 Healthcare 类公司，于 Feb 5, 2018 在 OTC 上市。截至最近交易日，NMRD 股价为 $0.00，市值约为 $8,070。过去12个月累计回报 +100.00%，年初至今回报 +19900.00%。

根据 2 位华尔街分析师，Nemaura Medical Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2023 财年 Nemaura Medical Inc. 营收 $77044.00，净利润 -$14.1M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Nemaura Medical Inc.（NMRD）股价为 $0.00，在 OTC 上市，52周区间为 $0.00 – $0.00。

NMRD 最新股价NMRD quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议